查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1739309

人工智慧醫療診斷應用的全球市場

Artificial Intelligence Medical Diagnosis App
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 172 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2030年，全球人工智慧醫療診斷應用市場規模將達33億美元

全球人工智慧醫療診斷應用市場規模預計在2024年達到12億美元，預計2024年至2030年期間的複合年成長率為19.0%，到2030年將達到33億美元。雲端部署是本報告分析的細分市場之一，預計其複合年成長率為17.1%，到分析期結束時規模將達到21億美元。本地配置細分市場在分析期間的複合年成長率預計為22.9%。

美國市場規模估計為 3.061 億美元，中國市場預計複合年成長率為 18.0%

美國人工智慧醫療診斷應用市場規模預計在2024年達到3.061億美元。預計到2030年，作為世界第二大經濟體的中國市場規模將達到5.104億美元，在2024-2030年的分析期內，複合年成長率將達到18.0%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為17.2%和16.6%。在歐洲，預計德國市場的複合年成長率約為14.2%。

全球人工智慧醫療診斷應用市場—主要趨勢與促進因素摘要

為什麼基於人工智慧的醫療診斷應用程式成為數位健康轉型的核心？

人工智慧 (AI) 驅動的醫療診斷應用程式正成為不斷發展的數位醫療領域不可或缺的一部分，它們能夠直接向患者和臨床醫生提供快速、便捷、數據驅動的主動診斷。這些應用程式使用機器學習演算法、影像識別、自然語言處理 (NLP) 和預測分析來評估症狀、分析醫療數據並產生機率診斷和分診建議。它們的效用在於能夠及時洞察疾病的早期發現，減少不必要的臨床就診，並支持遠距會診，尤其是在初級保健、皮膚科、放射科、眼科和慢性病管理領域。

全球對以患者為中心的醫療服務、醫療保健去中心化以及數位化優先醫療系統的重視，正在推動此類解決方案的採用。 AI 診斷應用程式透過幫助使用者解讀症狀、確定護理路徑的優先順序以及導航至合適的醫療資源來提高效率。對於醫療服務提供者而言，這些工具透過協助鑑別診斷、自動化文件處理和標記高風險病例，改善了臨床決策和診療效率。在醫療成本不斷上漲、業務短缺的背景下，AI 驅動的診斷應用程式越來越被視為一種經濟高效且可擴展的擴展第一線醫療服務的方式。

人工智慧模型和醫療數據生態系統如何提高診斷準確性？

人工智慧模型開發及其與臨床數據生態系統整合的進步，顯著提升了醫療診斷應用程式的準確性和可用性。基於大型去識別化資料集（包括電子健康記錄(EHR)、影像檔案、實驗室結果和患者報告資料）訓練的監督學習演算法，使這些應用程式能夠識別疾病模式、識別合併症並提供針對特定疾病的風險評估。自然語言處理 (NLP) 演算法支援症狀檢查介面，該介面可解釋自由文字輸入，並使用 SNOMED CT 和 ICD-10 等臨床本體來提案可能的疾病。

深度學習和卷積類神經網路(CNN) 在視覺診斷領域特別有效，例如在皮膚科影像中檢測皮膚癌，在視網膜掃描中識別糖尿病視網膜病變，以及在胸部 X 光片中分析肺炎和結核病。一些應用程式正在整合穿戴式裝置和感測器數據，在心律不整檢測、睡眠障礙和呼吸監測等領域提供即時診斷。雲端基礎平台能夠根據新的臨床證據和使用者回饋進行即時更新和模型再訓練，從而提升應用程式的適應性。隨著資料互通性和聯邦學習的成熟，這些應用程式正變得更加準確、可解釋，並符合臨床檢驗標準。

市場需求在哪裡加速成長以及哪些使用案例正在引領採用？

已開發市場和新興市場對基於人工智慧的醫療診斷應用的需求都在快速成長，其中美國、歐洲和亞太地區尤為突出。在北美，遠端醫療的整合、智慧型手機的高普及率以及數位療法和人工智慧臨床工具日益成長的監管勢頭，正在推動應用的普及。在歐洲，數位醫療改革和廣泛的國有化醫療體系，使得人工智慧診斷應用能夠融入公共醫療工作流程。同時，在亞太地區，行動裝置使用率高、農村地區難以獲得醫療專業人員以及政府主導的數位醫療舉措，正在推動應用的快速普及。

主要使用案例包括用於自我診斷的症狀檢查應用程式、客服中心和聊天機器人中使用的人工智慧分診助理、皮膚科影像分析應用程式、眼科篩檢應用程式以及放射科預篩檢工具。慢性病管理應用程式，尤其是針對糖尿病、高血壓和氣喘的應用程式，也正在整合人工智慧來解讀生物特徵資訊並提案即時干預建議。基於語音和臉部表情分析的心理健康診斷是新的前沿領域。企業應用程式也不斷擴展，保險公司和醫院網路正在部署人工智慧應用程式，以減少欺詐性索賠、最佳化病人歷程，並在遠端患者監護程序中標記早期預警訊號。

是什麼推動了人工智慧醫療診斷應用的全球成長？

AI醫療診斷應用市場的成長受到多個關鍵因素的推動，包括消費者對按需健康資訊的需求不斷成長、慢性病盛行率不斷上升，以及人工智慧、行動運算和醫學影像領域的技術進步。關鍵促進因素包括數位健康平台的整合、患者賦權趨勢，以及對可擴展解決方案的需求，以彌合都市區和服務不足地區的診斷差距。 COVID-19疫情表明，遠距離診斷是分診、檢測和追蹤的重要工具，這進一步加速了其應用。

資金籌措、醫療技術加速器以及人工智慧新興企業、醫療技術公司和醫療保健提供者之間的策略夥伴關係正在刺激快速創新和商業化。 FDA 和 CE 等監管機構擴大為臨床級人工智慧應用程式核准提供清晰的框架，符合 HIPAA/GDPR 的架構解決了隱私和信任障礙。與 EHR、遠端醫療平台 API 和多語言介面的整合使這些應用程式更加方便用戶使用且具有上下文感知能力。隨著人工智慧診斷工具從症狀檢查器發展到針對特定症狀的診斷助手，一個關鍵問題出現了：人工智慧驅動的診斷應用程式能否提供安全、公正且經過臨床檢驗的解決方案？

部分

配置（雲端、本地）；應用（放射學、病理學、循環系統、皮膚病學和其他應用）；最終用戶（醫院、診斷中心、診所和其他最終用戶）

受訪公司範例（值得關注的36家公司）

  • Ada Health
  • AI Medical Service
  • AIDoc
  • AliveCor
  • Arterys
  • Babylon Health
  • Bay Labs
  • Binah.ai
  • Buoy Health
  • Butterfly Network
  • Caption Health
  • Corti
  • Eko Health
  • Enlitic
  • GE Healthcare
  • Google Health
  • IBM Watson Health
  • iCAD
  • Infermedica
  • Lunit

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口（成品和原始OEM）來預測其競爭地位的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括人為提高銷貨成本、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

全球產業分析師密切關注來自全球頂尖首席經濟學家（14,949位）、智庫（62家）以及貿易和產業協會（171家）的專家的意見，以評估其對生態系統的影響並應對新的市場現實。我們追蹤了來自每個主要國家的專家和經濟學家對關稅及其對本國影響的看法。

全球產業分析師預計，這場動盪將在未來2-3個月內逐漸平息，新的世界秩序將更加清晰地建立。全球產業分析師正在即時追蹤這些事態發展。

2025年4月：談判階段

在4月的報告中，我們將探討關稅對全球整體市場的影響，並提供區域市場調整。我們的預測是基於歷史數據和不斷變化的市場影響因素。

2025年7月：最終關稅調整

在各國宣布最終重置後，客戶將在 7 月收到免費更新，最終更新將包含明確的關稅影響分析。

相互和雙邊貿易及關稅影響分析：

美國<>中國<>墨西哥<>加拿大<>歐盟<>日本<>印度<>其他176個國家

領先的產業經濟學家：全球產業分析師知識庫追蹤了 14,949 位經濟學家，其中包括來自民族國家、智庫、貿易和產業協會、大型企業以及各領域專家的最具影響力的首席經濟學家，他們共用了這場前所未有的全球經濟狀況模式轉移的影響。我們超過 16,491 份報告大多遵循基於里程碑的兩階段發布計劃。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 比賽

簡介目錄
Product Code: MCP33466

Global Artificial Intelligence Medical Diagnosis App Market to Reach US$3.3 Billion by 2030

The global market for Artificial Intelligence Medical Diagnosis App estimated at US$1.2 Billion in the year 2024, is expected to reach US$3.3 Billion by 2030, growing at a CAGR of 19.0% over the analysis period 2024-2030. Cloud Deployment, one of the segments analyzed in the report, is expected to record a 17.1% CAGR and reach US$2.1 Billion by the end of the analysis period. Growth in the On-Premise Deployment segment is estimated at 22.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$306.1 Million While China is Forecast to Grow at 18.0% CAGR

The Artificial Intelligence Medical Diagnosis App market in the U.S. is estimated at US$306.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$510.4 Million by the year 2030 trailing a CAGR of 18.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 17.2% and 16.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.2% CAGR.

Global Artificial Intelligence Medical Diagnosis App Market - Key Trends & Drivers Summarized

Why Are AI-Based Medical Diagnosis Apps Becoming Central to Digital Health Transformation?

Artificial Intelligence (AI)-powered medical diagnosis apps are becoming integral to the evolving landscape of digital healthcare by delivering rapid, accessible, and data-driven preliminary diagnostics directly to patients and clinicians. These apps use machine learning algorithms, image recognition, natural language processing (NLP), and predictive analytics to assess symptoms, analyze medical data, and generate probabilistic diagnoses or triage recommendations. Their utility lies in offering timely insights for early disease detection, reducing unnecessary clinical visits, and supporting remote care delivery-especially in primary care, dermatology, radiology, ophthalmology, and chronic disease management.

The global emphasis on patient-centered care, healthcare decentralization, and digital-first medical systems is propelling adoption of these solutions. AI diagnostic apps enhance efficiency by helping users interpret symptoms, prioritize care pathways, and navigate to appropriate healthcare resources. For healthcare providers, these tools assist in differential diagnosis, automate documentation, and flag high-risk cases, thereby improving clinical decision-making and operational throughput. Amid rising healthcare costs and physician shortages, AI-powered diagnostic applications are increasingly viewed as cost-effective, scalable extensions of frontline medical services.

How Are AI Models and Medical Data Ecosystems Enhancing Diagnostic Precision?

Advancements in AI model development and integration with clinical data ecosystems are significantly improving the accuracy and usability of medical diagnosis apps. Supervised learning algorithms trained on large, anonymized datasets-from electronic health records (EHRs), imaging archives, lab results, and patient-reported data-enable these apps to recognize disease patterns, identify comorbidities, and offer condition-specific risk assessments. Natural language processing (NLP) algorithms power symptom-checker interfaces that interpret free-text input and suggest likely conditions using clinical ontologies such as SNOMED CT and ICD-10.

Deep learning and convolutional neural networks (CNNs) are especially impactful in visual diagnostics-such as detecting skin cancer from dermatology images, identifying diabetic retinopathy in retinal scans, or analyzing chest X-rays for pneumonia or tuberculosis. Some apps integrate wearable and sensor data to provide real-time diagnostics in areas like arrhythmia detection, sleep disorders, and respiratory monitoring. Cloud-based platforms are enabling real-time updates and model retraining based on new clinical evidence and user feedback, enhancing app adaptability. As data interoperability and federated learning mature, these apps are becoming more accurate, explainable, and compliant with clinical validation standards.

Where Is Market Demand Accelerating and Which Use Cases Are Leading Adoption?

Market demand for AI-based medical diagnosis apps is growing rapidly in both developed and emerging markets, with significant traction in the U.S., Europe, and Asia-Pacific. In North America, adoption is driven by telemedicine integration, high smartphone penetration, and favorable regulatory momentum toward digital therapeutics and AI-enabled clinical tools. In Europe, digital health reforms and widespread use of national health systems are enabling integration of AI diagnostic apps into public healthcare workflows. Meanwhile, Asia-Pacific is seeing fast adoption due to high mobile usage, limited access to healthcare professionals in rural areas, and government-led digital health initiatives.

Leading use cases include symptom-checker apps for self-assessment, AI-powered triage assistants used in call centers or chatbots, dermatology image analyzers, ophthalmic screening apps, and radiology pre-screening tools. Chronic condition management apps, especially for diabetes, hypertension, and asthma, are also incorporating AI to interpret biometrics and suggest real-time interventions. Mental health diagnostics based on speech and facial expression analytics are an emerging frontier. Enterprise use is also growing, with insurers and hospital networks deploying AI apps to reduce claims fraud, optimize patient journeys, and flag early warning signs in remote patient monitoring programs.

What Is Driving the Global Growth of AI Medical Diagnosis Apps?

The growth in the AI medical diagnosis app market is driven by several key factors, including rising consumer demand for on-demand health information, increasing chronic disease prevalence, and technological advancements in AI, mobile computing, and medical imaging. A critical driver is the convergence of digital health platforms, patient empowerment trends, and the need for scalable solutions to bridge diagnostic gaps in both urban and underserved regions. COVID-19 further accelerated adoption by validating remote diagnostics as essential tools for triaging, testing, and follow-up.

Venture funding, healthtech accelerators, and strategic partnerships between AI startups, medtech firms, and healthcare providers are fueling rapid innovation and commercialization. Regulatory bodies like the FDA and CE are increasingly providing clear frameworks for clinical-grade AI app approval, while HIPAA/GDPR-compliant architectures are addressing privacy and trust barriers. Integration with EHRs, APIs for telehealth platforms, and multilingual interfaces are making these apps more usable and context-aware. As AI diagnostic tools evolve from symptom checkers to condition-specific diagnostic assistants, a key question arises: Can artificial intelligence-powered diagnosis apps deliver safe, equitable, and clinically validated solutions that extend diagnostic intelligence beyond the clinic and into the hands of every user?

SCOPE OF STUDY:

The report analyzes the Artificial Intelligence Medical Diagnosis App market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Deployment (Cloud, On-Premise); Application (Radiology, Pathology, Cardiology, Dermatology, Other Applications); End-User (Hospitals, Diagnostic Centers, Clinics, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 36 Featured) -

  • Ada Health
  • AI Medical Service
  • AIDoc
  • AliveCor
  • Arterys
  • Babylon Health
  • Bay Labs
  • Binah.ai
  • Buoy Health
  • Butterfly Network
  • Caption Health
  • Corti
  • Eko Health
  • Enlitic
  • GE Healthcare
  • Google Health
  • IBM Watson Health
  • iCAD
  • Infermedica
  • Lunit

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Artificial Intelligence Medical Diagnosis App - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Smartphone-Based AI Medical Diagnosis Apps Democratize Access to Early Health Screening
    • Clinical-Grade Algorithms Drive Accuracy of AI Medical Diagnosis Apps in Real-World Settings
    • AI-Powered Apps Expand Telehealth Capabilities With Instant Diagnostic Support
    • Symptom Checkers Integrated With AI Apps Enhance Patient Triage and Navigation
    • Remote Monitoring Features Embedded in AI Diagnosis Apps Improve Chronic Disease Management
    • Regulatory Validation and CE/FDA Approvals Boost Trust in AI-Powered Diagnosis Apps
    • Multi-Language and Voice Recognition Features Improve AI App Accessibility in Diverse Populations
    • Behavioral Health and Dermatology Emerge as Key Focus Areas for AI Medical Diagnosis Apps
    • Real-Time Feedback and Learning Loops Enhance Diagnostic Precision in AI Health Apps
    • Wearable Sync Capabilities Augment Data Streams for AI Diagnosis Applications
    • Consumer Health Ecosystems Evolve Around AI Medical Apps for Proactive Wellness Management
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Intelligence Medical Diagnosis App Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Cloud by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for On-Premise by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Radiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Radiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Pathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Pathology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Dermatology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Dermatology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Intelligence Medical Diagnosis App Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • JAPAN
    • Artificial Intelligence Medical Diagnosis App Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • CHINA
    • Artificial Intelligence Medical Diagnosis App Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: China 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 48: China Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • EUROPE
    • Artificial Intelligence Medical Diagnosis App Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • FRANCE
    • Artificial Intelligence Medical Diagnosis App Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 58: France Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: France 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • GERMANY
    • Artificial Intelligence Medical Diagnosis App Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Germany 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • ITALY
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Italy 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • UNITED KINGDOM
    • Artificial Intelligence Medical Diagnosis App Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 76: UK Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: UK 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Intelligence Medical Diagnosis App Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2025 & 2030
    • TABLE 96: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by End-user - Clinics, Other End-Users, Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Rest of World 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by End-user - Percentage Breakdown of Value Sales for Clinics, Other End-Users, Hospitals and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence Medical Diagnosis App by Application - Radiology, Pathology, Cardiology, Dermatology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World 6-Year Perspective for Artificial Intelligence Medical Diagnosis App by Application - Percentage Breakdown of Value Sales for Radiology, Pathology, Cardiology, Dermatology and Other Applications for the Years 2025 & 2030

IV. COMPETITION